(University of California - San Francisco) Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found.
Original Article: Common pain reliever can improve survival in head and neck cancer